Neuroone Medical Technologies Corp
NMTC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001500198
In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 1 sale; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.30M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Neuroone Medical Technologies Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $67.0K in total
- Open-market sells
- 1 filing
- 1 insider, $31.8K in total
- Insiders trading
- 2
- Net value
- +$35.2K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Neuroone Medical Technologies Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wambeke David J. | Chief Business Officer | 199,999 | Sep 8, 2026 | 2 |
| Johns Emily J. | Chief Administrative Officer | – | Aug 28, 2026 | 1 |
| Volker Christopher | Chief Financial Officer | 75,000 | Aug 28, 2026 | 1 |
| Christianson Mark | Market Development Director | 20,692 | Aug 28, 2026 | 8 |
| Mertens Steve | Chief Technology Officer | 152,141 | Aug 28, 2026 | 5 |
| Rosa David A | CEO & President | 1,080,132 | Aug 28, 2026 | 5 |
| Buckman Paul | Director | 178,733 | Apr 7, 2026 | 1 |
| Mathiesen Jeffrey S | Director | 156,343 | Apr 7, 2026 | 1 |
| Andrle Edward | Director | 133,932 | Apr 7, 2026 | 1 |
| Mills Jason Richard | Director | 49,687 | Apr 7, 2026 | 2 |
| McClurg Ronald W. | Chief Financial Officer | 444,117 | Apr 21, 2025 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 (view filing)8:31 AM ET | Aug 27 | 12 daysLate | Wambeke David J.Chief Business Officer | PPurchase | +33.3K | $2.01 | +$67.0K | +20.0%200.0K after | |
| Jul 2, 2026 (view filing)4:39 PM ET | Jun 30 | 2 days | Christianson MarkMarket Development Director | SSale | −10.0K | $3.18 | −$31.8K | −32.6%20.7K after | |
| Apr 1, 2026 (view filing) | Mar 30 | 2 days | Christianson MarkBusiness Development Director | SSale | −15.4K | $0.74 | −$11.4K | −7.2%198.9K after | |
| Mar 16, 2026 (view filing) | Mar 12-13 | 4 days | Christianson MarkBusiness Development Director | SSale | −917 | $0.80 | −$733.6 | −0.4%214.3K after | 2 lots |
| Mar 12, 2026 (view filing) | Mar 10-11 | 2 days | Christianson MarkBusiness Development Director | SSale | −13.7K | $0.80 | −$11.0K | −6.0%215.2K after | 2 lots |
| Mar 3, 2026 (view filing) | Mar 1 | 2 days | Wambeke David J.Chief Business Officer | PPurchase | +1.00M | $0.67 | +$670.0K | New position1.00M after | |
| Sep 9, 2025 (view filing) | Sep 5 | 4 days | Christianson MarkBusiness Development Director | SSale | −30.0K | $0.74 | −$22.2K | −11.5%231.2K after | |
| Jun 5, 2025 (view filing) | Jun 4 | 1 day | Christianson MarkBusiness Development Director | SSale | −10.0K | $0.58 | −$5.80K | −3.7%261.5K after | |
| May 23, 2025 (view filing) | May 21-22 | 2 days | Christianson MarkBusiness Development Director | SSale | −8.98K | $0.62 | −$5.57K | −3.2%271.5K after | 2 lots |
| May 21, 2025 (view filing) | May 19-20 | 2 days | Christianson MarkBusiness Development Director | SSale | −11.0K | $0.6673 | −$7.35K | −3.8%280.5K after | 2 lots |
| Apr 7, 2025 (view filing) | Apr 4 | 3 days | McClurg Ronald W.Chief Financial Officer | PPurchase | +200.0K | $0.50 | +$100.0K | +81.9%444.1K after | |
| Apr 7, 2025 (view filing) | Apr 4 | 3 days | Rosa David ACEO and President | PPurchase | +100.0K | $0.50 | +$50.0K | +9.4%1.16M after | |
| Jun 11, 2024 (view filing) | Jun 6 | 5 daysLate | Christianson MarkBusiness Development Director | SSale | −2.19K | $0.88 | −$1.93K | −0.7%295.0K after | |
| Jun 7, 2024 (view filing) | Jun 5 | 2 days | Christianson MarkBusiness Development Director | SSale | −25.8K | $0.88 | −$22.7K | −8.0%297.2K after | |
| Dec 27, 2023 (view filing) | Dec 26-27 | 1 day | Christianson MarkBusiness Development Director | SSale | −38.3K | $1.44 | −$55.2K | −11.3%300.6K after | 2 lots |
| Dec 26, 2023 (view filing) | Dec 21 | 5 days | Volker ChristopherChief Operating Officer | PPurchase | +75.0K | $1.40 | +$105.0K | New position75.0K after | |
| Dec 26, 2023 (view filing) | Dec 21-22 | 5 days | Christianson MarkBusiness Development Director | SSale | −11.7K | $1.40 | −$16.4K | −3.3%338.9K after | 2 lots |
| Sep 14, 2023 (view filing) | Sep 13 | 1 day | McClurg Ronald W.Chief Financial Officer | PPurchase | +50.9K | $0.98 | +$49.9K | +64.0%130.4K after | |
| Mar 24, 2023 (view filing) | Mar 21-23 | 3 daysLate | Christianson MarkBusiness Development Director | SSale | −26.5K | $1.51 | −$40.1K | −7.3%337.5K after | 3 lots |
| Jun 16, 2022 (view filing) | Jun 15 | 1 day | McClurg Ronald W.Chief Financial Officer | PPurchase | +10.0K | $1.02 | +$10.2K | +17.5%67.0K after | |
| Jun 14, 2022 (view filing) | Jun 10 | 4 days | McClurg Ronald W.Chief Financial Officer | PPurchase | +14.0K | $1.06 | +$14.8K | +32.6%57.0K after | |
| May 24, 2022 (view filing) | May 20-24 | 4 days | McClurg Ronald W.Chief Financial Officer | PPurchase | +28.0K | $0.8988 | +$25.2K | +186.7%43.0K after | 2 lots |
| Feb 4, 2022 (view filing) | Jun 23-24, 2021 | 226 days | Christianson MarkBusiness Development Director | SSale | −11.9K | $6.72 | −$79.9K | −3.3%351.2K after | Amended2 lots |